Rongchang Biopharmaceutical
Rongchang Biopharmaceutical
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, interstitial lung disease, lung disorder, respiratory system disorder, systemic lupus erythematosus | Recruiting | Phase 4 | 2026-01-27 | NCT07077486 |